Spike Pharmaceuticals Enters Infant Drug Market
Release time:
2020-07-31
Jinder Baby Drug Co., Ltd. Established
Jianfeng Pharmaceutical to Enter Infant Drug Market
News Recently, Zhejiang Jinder Baby Drug Co., Ltd., a Sino-German joint venture controlled by Jianfeng Pharmaceutical, completed registration. Jianfeng Pharmaceutical will use this as a basis to introduce German technology and products and develop the infant drug market.
Zhejiang Jinder Baby Drug Co., Ltd. was jointly funded by Jianfeng Pharmaceutical Co., Ltd., Germany Gefu Pharmaceutical Co., Ltd. and Zhuhai Hengqin Deyunjia International Trade Co., Ltd., with a registered capital of 2000 yuan, of which Jianfeng Pharmaceutical Co., Ltd. contributed 1100 yuan in cash, accounting for 55% of the registered capital ; ge Fu Pharmaceutical invested ,500 yuan, accounting for 25% of the registered capital, with two proprietary technologies of "diazepam suppository" and "paracetamol suppository". De Yunjia contributed 400 yuan in cash, accounting for 20% of the registered capital. The company's registered address is in Jinxi Development Zone, Jinhua City. It will rent the existing factory building of Jianfeng Pharmaceutical Jinxi Pharmaceutical Factory for renovation, and strive to absorb their respective expertise and adopt appropriate advanced technology and scientific management methods. A modern pharmaceutical enterprise focusing on the research and development, production and sales of pharmaceutical preparations for infants and children.
In this cooperation, Gefu Pharmaceuticals has invested in "diazepam suppository" and "acetaminophen suppository" with proprietary technology evaluation. The corresponding products have been listed in Germany, among which diazepam suppository is a therapeutic drug for anti-anxiety, sleep disorder and muscle tension. Acetaminophen is used for fever caused by cold or cold, and is also used to relieve mild to moderate pain. After the establishment of the joint venture company, it will carry out research and development and operation of corresponding products on the basis of these two proprietary technologies.
With the adjustment of my country's population policy and the implementation of the "comprehensive two-child" policy, it is expected that the infant drug market will usher in opportunities for rapid growth. This time, through the establishment of a joint venture company and the introduction of German technology to develop infant drugs, It is an important step taken by Jianfeng Pharmaceutical in response to market demand, and it is also the specific implementation of the company's development strategic plan to expand and strengthen its pharmaceutical business. (this newspaper reporter)
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page